Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery

Journal of Clinical Anesthesia

Volumn 9, Issue 2, 1997, Pages 97-102

  Morgan, Pamela J ^a   Chapados, Roger ^b   Chung, Frances F ^a   Gauthier, Marlene ^c   Knox, John W D ^d   Le Lorier, Jacques ^e  

^a UNIVERSITY OF TORONTO   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Insomnia, transient; sleep patterns, preoperative; triazolam

Indexed keywords

HYPNOTIC AGENT; PLACEBO; TRIAZOLAM; ZOLPIDEM;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SLEEP INDUCTION; SLEEP TIME; SOMNOLENCE;

EID: 0030900343     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(97)00236-5     Document Type: Article

References (30)

1. Bianchetti G, Dubruc C, Thiercelin JP, et al: Clinical pharmacokinetics of zolpidem in various physiological and pathological conditions. In: Sauvanet JP, Langer SZ, Morselli PL (eds): Imidazopyridines in Sleep Disorders. New York: Raven Press, 1988:155-63.
2. Thénot JP, Hermann P, Durand A, et al: Pharmacokinetics and metabolism of zolpidem in various species and in humans. In: Sauvanet JP, Langer SZ, Morselli PL (eds): Imidazopyridines in Sleep Disorders. New York: Raven Press, 1988:139-53.
3. Perrault G, Morel E, Sanger DJ, Zivkovic B: Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmacol 1990;187:487-94.
4. Benavides J, Peny B, Ruano D, Vitorica J, Scatton B: Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem. Brain Res 1993;604:240-50.
5. 5-subunit creates novel tvpe II benzodiazepine receptor pharmacology. J Neurochem 1990;54:1802-4.
6. Roth T, Roehrs T, Vogel G: Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. Sleep 1995;18:246-51.
7. Walsh JK, Schweitzer PK, Sugerman JL, Muehlbach MJ: Transient insomnia associated with a 3-hour phase advance of sleep time and treatment with zolpidem. J Clin Psychopharmacol 1990;10: 184-9.
8. Dockhorn RJ, Dockhorn DW: Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial. Clin Neuropharmacol (in press).
9. Scharf MB, Roth T, Vogel GW, Walsh JK: A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. J Clin Psychiatr 1994;55:192-9.
10. Merlotti L, Roehrs T, Koshorek G, Zorick F, Lamphere J, Roth T: The dose effects of zolpidem on the sleep of healthy normals. J Clin Psychopharmacol 1989;9:9-14.
11. Unden M, Roth-Schechter B: Next-day effects after nighttime treatment with zolpidem; a review. Eur Psychiatr 1996;11(suppl): 21-30.
12. Drugs and insomnia. NIH Consensus Development Conference. National Institutes of Health Consensus Development Conference Summary 1984;4:1-9.
13. Keighley MR, Gannon M, Warlow J, Jenkins CR, Gammon RJ: Evaluation of single-dose hypnotic treatment before elective operation. BMJ 1980;281:829-31.
14. Koffer H, Reichman RT, Rosenzwog BS, Shaeffer SL, Weiss SM: Comparative study of estazolam (E), flurazepam (F), and placebo (P) in pre-surgical patients complaining of insomnia. Clin Pharmacol Ther 1983;33:240.
15. Momose T: Effectiveness of zopiclone as a preoperative hypnotic. Pharmacology 1983;27 Suppl 2:196-204.
16. Kales A: Benzodiazepine hypnotics and insomnia. Hosp Pract 1990;25 Suppl 3:7-23.
17. Kales A, Manfredi RL, Vgontzas AN, Bixler EO, Vela-Bueno A, Fee EC: Rebound insomnia after only brief and intermittent use of rapidly eliminated benzodiazepines. Clinical Pharmacol Ther 1991;49:468-76.
18. Bixler EO, Kales A, Manfredi RL, Vgontzas AN, Tyson KL, Kales JD: Next-day memory impairment with triazolam use. Lancet 1991;337(8745):827-31.
19. Scharf MB, Fletcher K, Graham JP: Comparative amnestic effects of benzodiazepine hypnotic agents. J Clin Psychiatr 1988;49:134-7.
20. Balkin TJ, O'Donnell VM, Wesensten N, McCann U, Belenky G: Comparison of the daytime sleep and performance effects of zolpidem versus triazolam. Psychopharmacology 1992;107:83-8.
21. Berlin I, Warot D, Hergueta T, Molinier P, Bagot C, Puech AJ: Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performance, and postural sway in healthy subjects, J Clin Psychopharmacol 1993;13:100-6.
22. Rush CR, Griffiths RR: Zolpidem, triazolam, and temazepam: behavioral and subject-related effects in normal volunteers. J Clin Psychopharmacol 1996;16:146-57.
23. Kryger MH, Steljes D, Pouliot Z, Neufeld H, Odynski T: Subjective versus objective evaluation of hypnotic efficacy: experience with zolpidem. Sleep 1991;14:399-407.
24. Closs J: Assessment of sleep in hospital patients: a review of methods. J Adv Nurs 1988;13:501-10.
25. Rosenberg J, Ahlstrom F: Randomized, double-blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice. Scand J Primary Health Care 1994;12:88-92.
26. Surendrakumar D, Dunn M, Roberts CJ: Hospital admission and the start of benzodiazepine use. BMJ 1992;304(6831):881.
27. Rosenberg J, Rosenberg-Adamsen S, Kehlet H: Post-operative sleep disturbance: causes, factors and effects on outcome. Eur J Anaesthesiol 1995;10(Suppl):28-30.
28. Gillin JC, Spinweber CL, Johnson LC: Rebound insomnia: a critical review. J Clin Psychopharmacol 1989;9:161-72.
29. Kales A, Scharf MB, Kales JD, Soldatos CR: Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA 1979;241:1692-5.
30. Roehrs T, Merlotti L, Zorick F, Roth T: Sedative, memory, and performance effects of hypnotics. Psychopharmacology 1994;116: 130-4.